Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Gains from Sales and Divestitures (2016 - 2022)

Proto Labs' Gains from Sales and Divestitures history spans 10 years, with the latest figure at $37528.0 for Q1 2023.

  • For Q1 2023, Gains from Sales and Divestitures rose 6.59% year-over-year to $37528.0; the TTM value through Mar 2023 reached $37528.0, up 6.59%, while the annual FY2020 figure was $101941.0, 10.09% up from the prior year.
  • Gains from Sales and Divestitures for Q1 2023 was $37528.0 at Proto Labs, down from $120606.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $120606.0 in Q3 2022 and bottomed at $7113.0 in Q2 2020.
  • The 5-year median for Gains from Sales and Divestitures is $36367.5 (2022), against an average of $58899.2.
  • The largest annual shift saw Gains from Sales and Divestitures fell 0.87% in 2019 before it skyrocketed 1493.07% in 2021.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $92597.0 in 2019, then grew by 10.09% to $101941.0 in 2020, then rose by 11.16% to $113315.0 in 2021, then increased by 6.43% to $120606.0 in 2022, then tumbled by 68.88% to $37528.0 in 2023.
  • Per Business Quant, the three most recent readings for PRLB's Gains from Sales and Divestitures are $37528.0 (Q1 2023), $120606.0 (Q3 2022), and $35207.0 (Q1 2022).